Inhibitors of p97
US9089572B2 · kind B2 · utility
2Cited by
1References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 20, 2009 |
| Grant date | Jul 28, 2015 |
| Priority date | — |
| Expiry date | Nov 22, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
One aspect of the invention relates to compounds that inhibit the activity of p97, such as by binding covalently to a cysteine residue in the active site. In certain embodiments, the invention relates to the treatment of disease, such as cancer, comprising administering a compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.